Development of vaccines toward the global control and eradication of foot-and-mouth disease

References

• Loeffler F, Frosch P. Summarischer bericht ueber der ergebnisse der untersuchungen zur erforschung der maul- und klauenseuche. ZentBl. Bakt. Parasitkde22, 257–259 (1897).
   Google Scholar
• Brown F. The history of research in foot-and-mouth disease. Virus Res.91(1), 3–7 (2003).
   PubMed Web of Science ®Google Scholar
• Arzt J, Pacheco JM, Rodriguez LL. The early pathogenesis of foot-and-mouth disease in cattle after aerosol inoculation: identification of the nasopharynx as the primary site of infection. Vet. Pathol.47(6), 1048–1063 (2010).
   PubMedGoogle Scholar
• Pacheco JM, Arzt J, Rodriguez LL. Early events in the pathogenesis of foot-and-mouth disease in cattle after controlled aerosol exposure. Vet. J.183(1), 46–53 (2010).
   PubMed Web of Science ®Google Scholar
• Alexandersen S, Zhang Z, Donaldson AI. Aspects of the persistence of foot-and-mouth disease virus in animals – the carrier problem. Microbes Infect.4(10), 1099–1110 (2002).
   PubMed Web of Science ®Google Scholar
• Golde WT, Pacheco JM, Duque H et al. Vaccination against foot-and-mouth disease virus confers complete clinical protection in 7 days and partial protection in 4 days: use in emergency outbreak response. Vaccine23(50), 5775–5782 (2005).
   PubMedGoogle Scholar
• Lombard M, Pastoret PP, Moulin AM. A brief history of vaccines and vaccination. Rev. Sci. Tech.26(1), 29–48 (2007).
   PubMed Web of Science ®Google Scholar
• Brown F, Newman JF. In vitro measurement of the potency of inactivated foot-and-mouth disease virus vaccines. J. Hyg. (Lond.)61, 345–351 (1963).
   PubMedGoogle Scholar
• Bahnemann HG. Binary ethylenimine as an inactivant for foot-and-mouth disease virus and its application for vaccine production. Arch. Virol.47(1), 47–56 (1975).
   PubMed Web of Science ®Google Scholar
• Gay CG, Salt J, Balaski C. Challenges and opportunities in developing and marketing vaccines for OIE list A and emerging animal diseases. Dev. Biol. Stand.114, 209–216 (2003).
   Google Scholar
• Mattion N, Goris N, Willems T et al. Some guidelines for determining foot-and-mouth disease vaccine strain matching by serology. Vaccine27(5), 741–747 (2009).
   PubMed Web of Science ®Google Scholar
• Hunter P. The performance of southern African territories serotypes of foot and mouth disease antigen in oil-adjuvanted vaccines. Rev. Sci. Tech.15(3), 913–922 (1996).
   PubMedGoogle Scholar
• Iyer AV, Ghosh S, Singh SN, Deshmukh RA. Evaluation of three ‘ready to formulate’ oil adjuvants for foot-and-mouth disease vaccine production. Vaccine19(9–10), 1097–1105 (2000).
   PubMedGoogle Scholar
• Smitsaart E, Espinoza AM, Sanguinetti R, Filippi J, Ham A, Bellinzoni R. Addition of saponin to double oil emulsion FMD vaccines enhances specific antibody responses in cattle and pigs. In: Session of the Research Group of the Standing Technical Committee of the European Commission for the Control of FMD. European Commission (Ed.). Chania, Crete (Greece), 344–351(2004).
   Google Scholar
• The World Organisation for Animal Health. Guidelines for international standards for vaccine banks. In: Manual of Diagnostic Tests and Vaccines for Terrestrial Animals. The World Organisation for Animal Health (Ed.). Paris, France, 115–120 (2008).
   Google Scholar
• Eble PL, de Bruin MG, Bouma A, van Hemert-Kluitenberg F, Dekker A. Comparison of immune responses after intra-typic heterologous and homologous vaccination against foot-and-mouth disease virus infection in pigs. Vaccine24(9), 1274–1281 (2006).
   PubMedGoogle Scholar
• Cox SJ, Voyce C, Parida S et al. Protection against direct-contact challenge following emergency FMD vaccination of cattle and the effect on virus excretion from the oropharynx. Vaccine23(9), 1106–1113 (2005).
   PubMedGoogle Scholar
• Brehm KE, Kumar N, Thulke HH, Haas B. High potency vaccines induce protection against heterologous challenge with foot-and-mouth disease virus. Vaccine26(13), 1681–1687 (2008).
   PubMed Web of Science ®Google Scholar
• Barnett PV, Carabin H. A review of emergency foot-and-mouth disease (FMD) vaccines. Vaccine20(11–12), 1505–1514 (2002).
   PubMed Web of Science ®Google Scholar
• Salt JS, Barnett PV, Dani P, Williams L. Emergency vaccination of pigs against foot-and-mouth disease: protection against disease and reduction in contact transmission. Vaccine16(7), 746–754 (1998).
   PubMed Web of Science ®Google Scholar
• Parida S. Vaccination against foot-and-mouth disease virus: strategies and effectiveness. Exp. Rev. Vaccines8(3), 347–365 (2009).
   PubMed Web of Science ®Google Scholar
• Cox SJ, Aggarwal N, Statham RJ, Barnett PV. Longevity of antibody and cytokine responses following vaccination with high potency emergency FMD vaccines. Vaccine21(13–14), 1336–1347 (2003).
   PubMed Web of Science ®Google Scholar
• Cox SJ, Barnett PV, Dani P, Salt JS. Emergency vaccination of sheep against foot-and-mouth disease: protection against disease and reduction in contact transmission. Vaccine17(15–16), 1858–1868 (1999).
   PubMed Web of Science ®Google Scholar
• Cox SJ, Voyce C, Parida S et al. Effect of emergency FMD vaccine antigen payload on protection, sub-clinical infection and persistence following direct contact challenge of cattle. Vaccine24(16), 3184–3190 (2006).
   PubMedGoogle Scholar
• Rodriguez LL, Barrera J, Kramer E, Lubroth J, Brown F, Golde WT. A synthetic peptide containing the consensus sequence of the G–H loop region of foot-and-mouth disease virus type-O VP1 and a promiscuous T-helper epitope induces peptide-specific antibodies but fails to protect cattle against viral challenge. Vaccine21(25–26), 3751–3756 (2003).
   PubMed Web of Science ®Google Scholar
• Smitsaart E, Sanguinetti R, Filippi J, Ham A, Bellinzoni R. Addition of saponin to double oil emulsion FMD vaccines enhances specific antibody responses in cattle. In: Session of the Research Group of the Standing Technical Committee of the European Commission for the Control Of FMD. FAO (Ed.). FAO, Crete (Greece), 344–351 (2004).
   Google Scholar
• Smitsaart E, Mattion N, Filippi J et al. Enhancement of the immune response induced by the inclusion of saponin in oil-adjuvanted vaccines against foot-and-mouth disease. In: Session of the Research Group of the Standing Technical Commission for the Control of FMD. FOA, Borovets, Bulgaria, 255–262 (2000).
   Google Scholar
• Saraiva V. Vaccines and foot-and-mouth disease eradication in South America. Dev. Biol. (Basel)114, 67–77 (2003).
   PubMedGoogle Scholar
• Straub OC. Foot-and-mouth disease. Challenge of cattle after multiple vaccinations. Comp. Immunol. Microbiol. Infect. Dis.18(4), 253–257 (1995).
   PubMedGoogle Scholar
• Perez AM, Ward MP, Carpenter TE. Control of a foot-and-mouth disease epidemic in Argentina. Prev. Vet. Med.65(3–4), 217–226 (2004).
   PubMedGoogle Scholar
• Mattion N, Konig G, Seki C et al. Reintroduction of foot-and-mouth disease in Argentina: characterisation of the isolates and development of tools for the control and eradication of the disease. Vaccine22(31–32), 4149–4162 (2004).
   PubMed Web of Science ®Google Scholar
• Doel TR. FMD vaccines. Virus Res.91(1), 81–99 (2003).
   PubMed Web of Science ®Google Scholar
• Valtulini S, Macchi C, Ballanti P et al. Aluminum hydroxide-induced granulomas in pigs. Vaccine23(30), 3999–4004 (2005).
   PubMed Web of Science ®Google Scholar
• McKercher PD, Bachrach HL. A foot-and-mouth disease vaccine for swine. Can. J. Comp. Med.40(1), 67–74 (1976).
   PubMedGoogle Scholar
• Michelsen E. Experience with vaccination in pigs. Arch. Exp. Veterinarmed.15, 317–321 (1961).
   Google Scholar
• McCullough KC, De Simone F, Brocchi E, Capucci L, Crowther JR, Kihm U. Protective immune response against foot-and-mouth disease. J. Virol.66(4), 1835–1840 (1992).
   PubMed Web of Science ®Google Scholar
• Grubman MJ, Lewis SA, Morgan DO. Protection of swine against foot-and-mouth disease with viral capsid proteins expressed in heterologous systems. Vaccine11(8), 825–829 (1993).
   PubMedGoogle Scholar
• Taboga O, Tami C, Carrillo E et al. A large-scale evaluation of peptide vaccines against foot-and-mouth disease: lack of solid protection in cattle and isolation of escape mutants. J. Virol.71(4), 2606–2614 (1997).
   PubMed Web of Science ®Google Scholar
• Beard CW, Mason PW. Out on the farm with DNA vaccines. Nat. Biotechnol.16(13), 1325–1328 (1998).
   PubMedGoogle Scholar
• Grubman MJ. New approaches to rapidly control foot-and-mouth disease outbreaks. Expert Rev. Anti Infect. Ther.1(4), 579–586 (2003).
   PubMedGoogle Scholar
• Yang NS, Wang JH, Lin KF et al. Comparative studies of the capsid precursor polypeptide P1 and the capsid protein VP1 cDNA vectors for DNA vaccination against foot-and-mouth disease virus. J. Gene Med.7(6), 708–717 (2005).
   PubMedGoogle Scholar
• Ward G, Rieder E, Mason PW. Plasmid DNA encoding replicating foot-and-mouth disease virus genomes induces antiviral immune responses in swine. J. Virol.71(10), 7442–7447 (1997).
   PubMedGoogle Scholar
• Niborski V, Li Y, Brennan F et al. Efficacy of particle-based DNA delivery for vaccination of sheep against FMDV. Vaccine24(49–50), 7204–7213 (2006).
   PubMed Web of Science ®Google Scholar
• Chinsangaram J, Beard C, Mason PW, Zellner MK, Ward G, Grubman MJ. Antibody response in mice inoculated with DNA expressing foot-and-mouth disease virus capsid proteins. J. Virol.72(5), 4454–4457 (1998).
   PubMedGoogle Scholar
• Li Y, Stirling CM, Denyer MS et al. Dramatic improvement in FMD DNA vaccine efficacy and cross-serotype antibody induction in pigs following a protein boost. Vaccine26(21), 2647–2656 (2008).
   PubMed Web of Science ®Google Scholar
• Parry NR, Ouldridge EJ, Barnett PV et al. Serological prospects for peptide vaccines against foot-and-mouth disease virus. J. Gen. Virol.70( Pt 11), 2919–2930 (1989).
   PubMedGoogle Scholar
• Francis MJ, Hastings GZ, Syred AD, McGinn B, Brown F, Rowlands DJ. Non-responsiveness to a foot-and-mouth disease virus peptide overcome by addition of foreign helper T-cell determinants. Nature330(6144), 168–170 (1987).
   PubMed Web of Science ®Google Scholar
• DiMarchi R, Brooke G, Gale C, Cracknell V, Doel T, Mowat N. Protection of cattle against foot-and-mouth disease by a synthetic peptide. Science232(4750), 639–641 (1986).
   PubMed Web of Science ®Google Scholar
• Wang CY, Chang TY, Walfield AM et al. Effective synthetic peptide vaccine for foot-and-mouth disease in swine. Vaccine20(19–20), 2603–2610 (2002).
   PubMed Web of Science ®Google Scholar
• Beignon AS, Brown F, Eftekhari P et al. A peptide vaccine administered transcutaneously together with cholera toxin elicits potent neutralising anti-FMDV antibody responses. Vet. Immunol. Immunopathol.104(3–4), 273–280 (2005).
   PubMedGoogle Scholar
• Challa S, Barrette R, Rood D, Zinckgraf J, French R, Silbart L. Non-toxic Pseudomonas aeruginosa exotoxin A expressing the FMDV VP1 G–H loop for mucosal vaccination of swine against foot and mouth disease virus. Vaccine25(17), 3328–3337 (2007).
   PubMedGoogle Scholar
• Cubillos C, de la Torre BG, Jakab A et al. Enhanced mucosal immunoglobulin A response and solid protection against foot-and-mouth disease virus challenge induced by a novel dendrimeric peptide. J. Virol.82(14), 7223–7230 (2008).
   PubMed Web of Science ®Google Scholar
• Mayr GA, Chinsangaram J, Grubman MJ. Development of replication-defective adenovirus serotype 5 containing the capsid and 3C protease coding regions of foot-and-mouth disease virus as a vaccine candidate. Virology263(2), 496–506 (1999).
   PubMed Web of Science ®Google Scholar
• Pena L, Moraes MP, Koster M et al. Delivery of a foot-and-mouth disease virus empty capsid subunit antigen with nonstructural protein 2B improves protection of swine. Vaccine26(45), 5689–5699 (2008).
   PubMed Web of Science ®Google Scholar
• Ren X, Xue F, Zhu Y et al. Construction and identification of recombinant BHV-1 expressing foot and mouth disease virus VP1 gene. Wei Sheng Wu Xue Bao49(5), 677–682 (2009).
   PubMedGoogle Scholar
• Li J, Liu Y, Liu X et al. Screening and stability of Madin-Darby bovine kidney cell strain co-expressing the capsid precursor protein P1–2A gene and the protease 3C gene of foot-and-mouth disease virus. Wei Sheng Wu Xue Bao48(11), 1520–1525 (2008).
   PubMedGoogle Scholar
• Li Z, Yin X, Yi Y et al. FMD subunit vaccine produced using a silkworm-baculovirus expression system: protective efficacy against two type Asia1 isolates in cattle. Vet. Microbiol.149(1–2), 99–103 (2010).
   PubMedGoogle Scholar
• Cao Y, Lu Z, Sun J et al. Synthesis of empty capsid-like particles of Asia I foot-and-mouth disease virus in insect cells and their immunogenicity in guinea pigs. Vet. Microbiol.137(1–2), 10–17 (2009).
   PubMed Web of Science ®Google Scholar
• Li Z, Yi Y, Yin X, Zhang Z, Liu J. Expression of foot-and-mouth disease virus capsid proteins in silkworm-baculovirus expression system and its utilization as a subunit vaccine. PloS ONE3(5), e2273 (2008).
   PubMed Web of Science ®Google Scholar
• Balamurugan V, Renji R, Saha SN, Reddy GR, Gopalakrishna S, Suryanarayana VV. Protective immune response of the capsid precursor polypeptide (P1) of foot and mouth disease virus type ‘O’ produced in Pichia pastoris. Virus Res.92(2), 141–149 (2003).
   PubMedGoogle Scholar
• Li YG, Tian FL, Gao FS, Tang XS, Xia C. Immune responses generated by Lactobacillus as a carrier in DNA immunization against foot-and-mouth disease virus. Vaccine25(5), 902–911 (2007).
   PubMedGoogle Scholar
• Bachrach HL, Moore DM, McKercher PD, Polatnick J. Immune and antibody responses to an isolated capsid protein of foot-and-mouth disease virus. J. Immunol.115(6), 1636–1641 (1975).
   PubMed Web of Science ®Google Scholar
• Vidal M, Cairo J, Mateu MG, Villaverde A. Molecular cloning and expression of the VP1 gene of foot-and-mouth disease virus C1 in E. coli: effect on bacterial cell viability. Appl. Microbiol. Biotechnol.35(6), 788–792 (1991).
   PubMedGoogle Scholar
• Shi XJ, Wang B, Zhang C, Wang M. Expressions of bovine IFN-γ and foot-and-mouth disease VP1 antigen in P. pastoris and their effects on mouse immune response to FMD antigens. Vaccine24(1), 82–89 (2006).
   PubMedGoogle Scholar
• Shi XJ, Wang B, Wang M. Immune enhancing effects of recombinant bovine IL-18 on foot-and-mouth disease vaccination in mice model. Vaccine25(7), 1257–1264 (2007).
   PubMed Web of Science ®Google Scholar
• Su C, Duan X, Wang X et al. Heterologous expression of FMDV immunodominant epitopes and HSP70 in P. pastoris and the subsequent immune response in mice. Vet. Microbiol.124(3–4), 256–263 (2007).
   PubMed Web of Science ®Google Scholar
• Su CX, Duan XG, Wang XQ et al. Fusion expression of O type foot-and-mouth diseases virus VP1 gene and HSP70 gene and induction of immune responses in mice. Sheng Wu Gong Cheng Xue Bao22(5), 733–736 (2006).
   PubMedGoogle Scholar
• Clarke BE, Newton SE, Carroll AR et al. Improved immunogenicity of a peptide epitope after fusion to hepatitis B core protein. Nature330(6146), 381–384 (1987).
   PubMed Web of Science ®Google Scholar
• Zhang YL, Guo YJ, Wang KY et al. Enhanced immunogenicity of modified hepatitis B virus core particle fused with multiepitopes of foot-and-mouth disease virus. Scand. J. Immunol.65(4), 320–328 (2007).
   PubMedGoogle Scholar
• Carrillo C, Wigdorovitz A, Oliveros JC et al. Protective immune response to foot-and-mouth disease virus with VP1 expressed in transgenic plants. J. Virol.72(2), 1688–1690 (1998).
   PubMed Web of Science ®Google Scholar
• Carrillo C, Wigdorovitz A, Trono K et al. Induction of a virus-specific antibody response to foot and mouth disease virus using the structural protein VP1 expressed in transgenic potato plants. Viral Immunol.14(1), 49–57 (2001).
   PubMed Web of Science ®Google Scholar
• Dus Santos MJ, Carrillo C, Ardila F et al. Development of transgenic alfalfa plants containing the foot and mouth disease virus structural polyprotein gene P1 and its utilization as an experimental immunogen. Vaccine23(15), 1838–1843 (2005).
   PubMed Web of Science ®Google Scholar
• Huang Y, Liang W, Wang Y et al. Immunogenicity of the epitope of the foot-and-mouth disease virus fused with a hepatitis B core protein as expressed in transgenic tobacco. Viral Immunol.18(4), 668–677 (2005).
   PubMed Web of Science ®Google Scholar
• Chinsangaram J, Moraes MP, Koster M, Grubman MJ. Novel viral disease control strategy: adenovirus expressing α interferon rapidly protects swine from foot-and-mouth disease. J. Virol.77(2), 1621–1625 (2003).
   PubMed Web of Science ®Google Scholar
• Moraes MP, Mayr GA, Mason PW, Grubman MJ. Early protection against homologous challenge after a single dose of replication-defective human adenovirus type 5 expressing capsid proteins of foot-and-mouth disease virus (FMDV) strain A24. Vaccine20(11–12), 1631–1639 (2002).
   PubMed Web of Science ®Google Scholar
• Pacheco JM, Brum MC, Moraes MP, Golde WT, Grubman MJ. Rapid protection of cattle from direct challenge with foot-and-mouth disease virus (FMDV) by a single inoculation with an adenovirus-vectored FMDV subunit vaccine. Virology337(2), 205–209 (2005).
   PubMed Web of Science ®Google Scholar
• Grubman MJ, Moraes MP, Schutta C et al. Adenovirus serotype 5-vectored foot-and-mouth disease subunit vaccines: the first decade. Future Virol.5(1), 51–64 (2010).
   Web of Science ®Google Scholar
• Piccone ME, Rieder E, Mason PW, Grubman MJ. The foot-and-mouth disease virus leader proteinase gene is not required for viral replication. J. Virol.69(9), 5376–5382 (1995).
   PubMed Web of Science ®Google Scholar
• Mason PW, Piccone ME, McKenna TS, Chinsangaram J, Grubman MJ. Evaluation of a live-attenuated foot-and-mouth disease virus as a vaccine candidate. Virology227(1), 96–102 (1997).
   PubMed Web of Science ®Google Scholar
• Chinsangaram J, Mason PW, Grubman MJ. Protection of swine by live and inactivated vaccines prepared from a leader proteinase-deficient serotype A12 foot-and-mouth disease virus. Vaccine16(16), 1516–1522 (1998).
   PubMed Web of Science ®Google Scholar
• Mowat GN, Brooksby JB, Pay TW. Use of BHK 21 cells in the preparation of mouse attenuated live foot-and-mouth disease vaccines for the immunization of cattle. Nature196, 655–656 (1962).
   PubMedGoogle Scholar
• Martin WB, Edwards LT. A field trial in South Africa of an attenuated vaccine against foot-and-mouth disease. Res. Vet. Sci.6, 196–201 (1965).
   PubMedGoogle Scholar
• Zhidkov SA, Sergeev VA. A study of the properties of attenuated cold variant of type O foot-and-mouth disease virus. Veterinariia10, 29–31 (1969).
   PubMedGoogle Scholar
• Mowat GN, Barr DA, Bennett JH. The development of an attenuated foot-and-mouth disease virus vaccine by modification and cloning in tissue cultures of BHK21 cells. Arch. Gesamte Virusforsch.26(4), 341–354 (1969).
   PubMedGoogle Scholar
• Brown CC, Piccone ME, Mason PW, McKenna TS, Grubman MJ. Pathogenesis of wild-type and leaderless foot-and-mouth disease virus in cattle. J. Virol.70(8), 5638–5641 (1996).
   PubMed Web of Science ®Google Scholar
• Almeida MR, Rieder E, Chinsangaram J et al. Construction and evaluation of an attenuated vaccine for foot-and-mouth disease: difficulty adapting the leader proteinase-deleted strategy to the serotype O1 virus. Virus Res.55(1), 49–60 (1998).
   PubMed Web of Science ®Google Scholar
• Beard C, Ward G, Rieder E, Chinsangaram J, Grubman MJ, Mason PW. Development of DNA vaccines for foot-and-mouth disease, evaluation of vaccines encoding replicating and non-replicating nucleic acids in swine. J. Biotechnol.73(2–3), 243–249 (1999).
   PubMed Web of Science ®Google Scholar
• Blignaut B, Visser N, Theron J, Rieder E, Maree FF. Custom-engineered chimeric foot-and-mouth disease vaccine elicits protective immune responses in pigs. J. Gen. Virol. DOI: 10.1099/vir.0.027151-0 (2010) (Epub ahead of print).
   PubMedGoogle Scholar
• Maree FF, Blignaut B, de Beer TA, Visser N, Rieder EA. Mapping of amino acid residues responsible for adhesion of cell culture-adapted foot-and-mouth disease SAT type viruses. Virus Res.153(1), 82–91 (2010).
   PubMedGoogle Scholar
• Fowler VL, Paton DJ, Rieder E, Barnett PV. Chimeric foot-and-mouth disease viruses: evaluation of their efficacy as potential marker vaccines in cattle. Vaccine26(16), 1982–1989 (2008).
   PubMedGoogle Scholar
• Wu Q, Brum MC, Caron L, Koster M, Grubman MJ. Adenovirus-mediated type I interferon expression delays and reduces disease signs in cattle challenged with foot-and-mouth disease virus. J. Interferon Cytokine Res.23(7), 359–368 (2003).
   PubMedGoogle Scholar
• Moraes MP, de Los Santos T, Koster M et al. Enhanced antiviral activity against foot-and-mouth disease virus by a combination of type I and II porcine interferons. J. Virol.81(13), 7124–7135 (2007).
   PubMed Web of Science ®Google Scholar
• Dias CC, Moraes MP, Segundo FD, de Los Santos T, Grubman MJ. Porcine type I interferon rapidly protects swine against challenge with multiple serotypes of foot-and-mouth disease virus. J. Interferon Cytokine Res.31(2), 227–236 (2011).
   PubMedGoogle Scholar
• Chinsangaram J, Koster M, Grubman MJ. Inhibition of L-deleted foot-and-mouth disease virus replication by α/β interferon involves double-stranded RNA-dependent protein kinase. J. Virol.75(12), 5498–5503 (2001).
   PubMed Web of Science ®Google Scholar
• Chinsangaram J, Piccone ME, Grubman MJ. Ability of foot-and-mouth disease virus to form plaques in cell culture is associated with suppression of α/β interferon. J. Virol.73(12), 9891–9898 (1999).
   PubMed Web of Science ®Google Scholar
• Moraes MP, Chinsangaram J, Brum MC, Grubman MJ. Immediate protection of swine from foot-and-mouth disease: a combination of adenoviruses expressing interferon α and a foot-and-mouth disease virus subunit vaccine. Vaccine22(2), 268–279 (2003).
   PubMed Web of Science ®Google Scholar
• de Avila Botton S, Brum MC, Bautista E et al. Immunopotentiation of a foot-and-mouth disease virus subunit vaccine by interferon α. Vaccine24(17), 3446–3456 (2006).
   PubMed Web of Science ®Google Scholar
• De Clercq K, Goris N, Barnett PV, MacKay DK. The importance of quality assurance/quality control of diagnostics to increase the confidence in global foot-and-mouth disease control. Transbound Emerg. Dis.55(1), 35–45 (2008).
   PubMedGoogle Scholar
• Mackay DK, Forsyth MA, Davies PR, Salt JS. Antibody to the nonstructural proteins of foot-and-mouth disease virus in vaccinated animals exposed to infection. Vet. Q.20(Suppl. 2), S9–S11 (1998).
   PubMedGoogle Scholar
• Paton DJ, de Clercq K, Greiner M et al. Application of non-structural protein antibody tests in substantiating freedom from foot-and-mouth disease virus infection after emergency vaccination of cattle. Vaccine24(42–43), 6503–6512 (2006).
   PubMed Web of Science ®Google Scholar
• Kitching RP. Identification of foot and mouth disease virus carrier and subclinically infected animals and differentiation from vaccinated animals. Rev. Sci. Tech.21(3), 531–538 (2002).
   PubMedGoogle Scholar
• Robiolo B, Seki C, Fondevilla N et al. Analysis of the immune response to FMDV structural and non-structural proteins in cattle in Argentina by the combined use of liquid phase and 3ABC-ELISA tests. Vaccine24(7), 997–1008 (2006).
   PubMedGoogle Scholar
• Armstrong RM, Cox SJ, Aggarwal N et al. Detection of antibody to the foot-and-mouth disease virus (FMDV) non-structural polyprotein 3ABC in sheep by ELISA. J. Virol. Methods125(2), 153–163 (2005).
   PubMedGoogle Scholar
• Mason PW, Chinsangaram J, Moraes MP, Mayr GA, Grubman MJ. Engineering better vaccines for foot-and-mouth disease. Dev. Biol. (Basel)114, 79–88 (2003).
   PubMedGoogle Scholar
• Uttenthal A, Parida S, Rasmussen TB, Paton DJ, Haas B, Dundon WG. Strategies for differentiating infection in vaccinated animals (DIVA) for foot-and-mouth disease, classical swine fever and avian influenza. Expert. Rev. Vaccines9(1), 73–87 (2010).
   PubMed Web of Science ®Google Scholar
• Perry B, Sones K. Global roadmap for improving the tools to control foot-and-mouth disease in endemic settings: report of a workshop held at Agra, India, 29 November–1 December 2006, and subsequent roadmap outputs. International Livestock Research Institute, Nairobi, Kenya, 88 (2006).
   Google Scholar